Introduction
One of the major health problems faced by the health care professionals, pharmaceutical industry and drug regulatory agencies is liver injury induced by the drugs. 5 More than nine hundred medicines and toxin have been reported to induce liver damage. 6 Methotrexate which is hepatotoxic drug is used to treat different types of neoplasms. It is also used to treat inflammatory conditions such as rheumatoid arthritis and psoriasis. 7 In many autoimmune diseases such as pamphigus, uveitis and myasthenia gravis it is used as a first line drug. Therefore inspite of documented proofs that it can cause liver damage, a large number of patients are using this drug. 8 Methotrexate inhibit dihydrofolate reductase an enzyme which is essential for the synthesis of tetrahydrofolate. 9 For the nucleoside thymidine denovo synthesis, folic acid is needed. So the synthesis of thymidilate is indirectly affected by the Methotrexate which is essential for the synthesis of DNA. 10 reactive oxygen molecules such as hypochloride radicals, superoxide, hydroxyl radicals and hydrogen peroxide. 11 In allopathic medical practices no reliable drugs are available which provides protection to the liver so herbs play important role for the treatment of various liver diseases. 12 A number of reviews are published stating the importance of plant extracts in the diseases of the liver. 13 Turmeric (Curcuma Longa L, zingiberaceae), is a yellow-colored spice derived from the perennial herb, which has been widely used for centuries in traditional therapies for different diseases including cancer,inflammatory disorders, hepatitis and other liver disorders, skin diseases, Alzheimer's disease, rheumatoid arthritis. 14 Besides curcumin, Turmeric contains more than 300 other components, notably phenolics and terpenoids. 15 For free radicals Turmeric acts as a scavenger .It also inhibits production of Reactive oxygen species (ROS) like hydrogen peroxide and superoxide anions in vitro study. 16 In vivo study it also lowers generation of Reactive oxygen species. Thus free radicals induced liver toxicity is protected by Turmeric due to it antioxidant effects. 17 In the current study, using a mice model, the effects of Turmeric in Methotrexate -induced liver injury, are observed.
MATERIAL AND METHODS
This laboratory based randomized controlled trial was carried out at Animal House of IBMS (Institute of Basic Medical Science), from March to September 2018 by the permission of Ethical Committee of (KMU) Khyber Medical University Hayatabad Peshawar. 28 adult male albino mice (5 to 7 weeks) weighing 25 to 40 grams were kept in 12 hours/light 12 hours/dark cycle at a temperature of 20 ± C and were acclimatized for two weeks 28 adult male albino mice were divided into control Group A and experimental Groups, B, C and D. In Group A4 mice, and in Group B, C and D 08 mice were included. No drug was given to group A. Group B was given Turmeric extract per oral (400mg /kg) daily for 14 days. Group C was given Injection Methrotrexate (40mg/kg) intraperitoneally (I.P) on day 7. Group D was given Turmeric extract per oral (400mg /kg) daily for 7 days as pre administration to injection Methotrexate and on day 7 injection Methrotrexate (40mg/kg) was given intraperitoneally (I.P) and Turmeric extract per oral (400mg/kg) was given daily for further 7 days as post administration to injection Methotrexate.
All the animals were sacrificed on day 14. The liver was removed and preserved in formalin. Different sections of the liver were prepared by tissue processing. Eosin and Haematoxyline stain was applied. Tissues were observed under light microscope to study the histological parameters. Data was analyzed using SPSS version 21. The arithmetic means of observation was calculated. Standard deviation (SD) was calculated. According to result and variable, statistical significance was analyzed using Anovo test and Chi square test. P value <.05 was considered as statistically significant
RESULTS

Changes in diameter of central vein (Figure 1 and 2)
In this study analysis of diameter of central vein was done. Increase in diameter of central vein between groups was observed by the application of ANOVA test. The Methotrexate (Group C) showed a significant increase in the diameter of central vein with p value of 0.00. In the Methotrexate plus Turmeric (Group D) the diameter was increased as compared to control and Turmeric (Group B) but when (Group D) was compared to Group C, It was noted that the dilatation in (Group D) showed23cx slight decrease. (figure 1 and 2 
Congestion in central vein
P-Value
Congestion in central vein
Absent n=8
Absent n=8 marked n=8
Mild to moderate n=8 0.00 
CONCLUSION
In conclusion this study demonstrates clearly that administration of Curcuma Longa (Turmeric) protected hepatic tissue due to its antioxidant activity and it might have a capability to be used in the treatment regimen in future. Copyright© 20 Oct, 2019.
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Figure-I. Photomicrograph of liver of (MTX Group C)
Where "A" shows severe congestion in central vein at 40x. 
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